Novo Nordisk Medical Innovation Summit 2025
- SANTIAGO, chile – Medical specialists and health professionals from across Chile gathered on April 26 to exchange insights on managing diabetes and obesity, and to address the impact...
- the event drew nearly 100 guests and included 10 discussion blocks focused on optimizing patient care for diabetes and obesity.
- A panel of prominent speakers contributed their expertise, including Dr. Ana María Gómez, endocrinologist, and Dr.
Chilean Health Professionals Convene to Discuss Diabetes, Obesity Treatments
Table of Contents
SANTIAGO, chile – Medical specialists and health professionals from across Chile gathered on April 26 to exchange insights on managing diabetes and obesity, and to address the impact of these conditions on public health. The meeting, organized by Novo nordisk Chile, featured talks and activities centered on improving the control of these widespread diseases.
the event drew nearly 100 guests and included 10 discussion blocks focused on optimizing patient care for diabetes and obesity.
Expert perspectives on National challenges
A panel of prominent speakers contributed their expertise, including Dr. Ana María Gómez, endocrinologist, and Dr. Cristián Fernández; Dr. Verónica Mujica, diabetologist; Dr. Gonzalo Ramírez, nephrologist; and Dr. Sofía Araya, a nutritionist, along with Dr. Francisca Chávez.
Dr.Verónica Mujica expressed gratitude for the opportunity to participate. “I am grateful to have been invited to this meeting and to have shared with colleagues from diffrent medical areas a conversation so necessary for patients living with diabetes and obesity,” she said. “Spaces like this connect us with our vocation and allow the health area to continue progressing day by day.”
Eduardo Silotto, VP and general manager of Novo Nordisk Chile, emphasized the company’s commitment. “At Novo Nordisk, we are convinced that it is indeed increasingly necessary to generate new opportunities for those who have lived with stigmas and who today can have new tools to improve the quality of life of patients,” he said.
Renate Flaskamp, medical director of Novo Nordisk Chile, echoed this sentiment. “We are very happy with the results of the event. Our commitment is to continue promoting innovative solutions, which not only represent clinical advances, but also a real opportunity to transform people’s lives.”
Addressing Regional Disparities
Dr. Sofía Araya, a clinical nutritionist at the san Borja arriarán Clinical Hospital, addressed the challenges specific to Chile. “Chile,being a long and narrow country,we live different realities,but the public health problem is the same,” she stated. “We have levels of obesity and overflowing diabetes; the numbers tell us that today the prevalence is about 80% overweight and obesity, and diabetes is over 12-14%.”
Araya called for a more unified approach. “My ambition is that we stop being islands that work for particular efforts and this is given in something more powerful, than to give lights so that from public health institutions, better accesses and financing can be had for the management of these pathologies, which today do not exist.”
She further noted the importance of collaboration. “Today, the efforts are efforts of teams, individual hospitals, and therefore my ambition is that we try to grow as a country, giving better access in public health.” Araya also acknowledged Novo Nordisk’s role: “Novo Nordisk contributes with technology, with innovation, accompanies us, educates us, also inspires us and accompanies us in all our dreams and our follies that we want to undertake in public hospitals.”
Dr. Gonzalo ramírez, a nephrologist at Las Higueras de Talcahuano hospital, expressed his hopes for the summit. He aimed “to be able to connect with different specialists, nephrologists, diabetologists, internist doctors, who we are handling the patient with renal diabetic disease and being able to have new alternatives.” He added, “For me, it is indeed very interesting to be able to connect with different specialties, know our experiences.I believe that it is essential to be able to handle this line, in the context of education, accompanying, both of the teams, of the patients also… generate these events, for example, in which I as a nephrologist suddenly look at very kidney things, but the diabetologist, the internist, the endocrinologist will also give me another look with respect to how they use it; therefore, I think it allows us to connect with more people.”
Chilean Health Professionals Convene to Discuss diabetes, Obesity Treatments
Q: What was the main focus of the recent meeting of Chilean health professionals?
A: The primary goal of the gathering, wich took place on April 26th in Santiago, Chile, was to facilitate the exchange of insights on the management of diabetes and obesity. The discussions also addressed the notable impact these conditions have on public health. The event,organized by Novo Nordisk Chile,featured talks and activities aimed at improving the control of these widespread diseases.
Q: Who were the key participants at the meeting?
A: The meeting drew nearly 100 guests, primarily medical specialists and health professionals from across Chile. Expert speakers included Dr. Ana María Gómez (endocrinologist), Dr. Cristián Fernández, Dr.Verónica Mujica (diabetologist), Dr. Gonzalo Ramírez (nephrologist), Dr. Sofía araya (nutritionist), and Dr. Francisca Chávez.
Q: What were some of the key perspectives shared by the experts?
A: Dr. Verónica Mujica expressed gratitude for the chance to connect with colleagues from different medical areas to discuss issues crucial for patients living with diabetes and obesity.Eduardo Silotto, VP and General Manager of Novo Nordisk Chile, emphasized the need for new opportunities for those living with the stigmas associated with these conditions. Renate Flaskamp, Medical Director of Novo Nordisk Chile, highlighted the company’s commitment to promoting innovative solutions.
Q: What challenges related to diabetes and obesity are specific to Chile?
A: Dr. sofía araya, a clinical nutritionist, pointed out that Chile, due to its geography, faces diverse realities. Though, the public health problem is the same across the country, with high rates of obesity and diabetes.The prevalence of overweight and obesity is about 80%, and diabetes is over 12-14%.
Q: What actions were suggested to address these challenges?
A: Dr. Araya advocated for a more unified approach, moving away from individual efforts towards a more coordinated strategy. She emphasized the need for better access and financing from public health institutions for managing these pathologies. She also highlighted the importance of collaboration. Others agreed that the existing efforts (individual hospitals, teams) needed to expand to give better access in public health.
Q: What role did novo Nordisk play in the event?
A: Novo Nordisk Chile organized the meeting. In addition to this, Novo Nordisk contributes technology, innovation, education and inspiration , and supports initiatives in public hospitals.
Q: What were the goals of the nephrologist, Dr. Gonzalo Ramírez, for the summit?
A: Dr.Gonzalo Ramírez aimed to connect with various specialists to share knowledge and experience. He hoped to “connect with different specialists, nephrologists, diabetologists, internist doctors, who we are handling the patient with renal diabetic disease and being able to have new alternatives.” He wanted to foster an environment for education and support for both teams and patients.